China Shineway Pharmaceutical Group Limited (C1S) — Cash Flow Reinvestment Rate

Latest as of June 2023: 0.17x

China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow Reinvestment Rate of 0.17x as of June 2023, reinvesting €26.64 Million (capex €24.57 Million plus investments €2.06 Million) from operating cash flow of €160.69 Million. Explore China Shineway Pharmaceutical Group Limi capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.17x
(Capex + Investments) / Operating CF

Total Reinvested

€26.64 Million
Capex + Investments

Operating Cash Flow

€160.69 Million
EUR

Capital Expenditures

€24.57 Million
EUR

China Shineway Pharmaceutical Group Limited Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for China Shineway Pharmaceutical Group Limited across 13 annual periods. Also explore total assets of China Shineway Pharmaceutical Group Limi for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for China Shineway Pharmaceutical Group Limited (2013–2025)

Year-by-year capital reinvestment analysis for China Shineway Pharmaceutical Group Limited. For live market cap and broader valuation context, see China Shineway Pharmaceutical Group Limi (C1S) total market value.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.30x €348.24 Million €1.17 Billion €197.91 Million ▼ -37.4%
2024 0.48x €457.50 Million €963.13 Million €140.11 Million ▲ +186.1%
2023 0.17x €154.86 Million €932.63 Million €144.32 Million ▲ +35.4%
2022 0.12x €136.13 Million €1.11 Billion €129.46 Million ▼ -15.7%
2021 0.15x €102.37 Million €703.15 Million €93.63 Million ▼ -15.4%
2020 0.17x €109.93 Million €638.57 Million €66.03 Million ▼ -40.4%
2019 0.29x €106.33 Million €368.00 Million €88.40 Million ▲ +13.1%
2018 0.26x €136.07 Million €532.59 Million €127.34 Million ▲ +24.7%
2017 0.20x €100.56 Million €490.65 Million €91.83 Million ▼ -19.4%
2016 0.25x €186.50 Million €733.53 Million €106.79 Million ▲ +24.8%
2015 0.20x €151.71 Million €744.71 Million €106.56 Million ▼ -12.1%
2014 0.23x €179.20 Million €773.16 Million €104.18 Million ▼ -60.9%
2013 0.59x €308.46 Million €519.89 Million €261.89 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow